Create a narrative

Sun Pharmaceutical Industries Community

NSEI:SUNPHARMA Community

1 Narratives written by author
0 Comments on narratives written by author
20 Fair Values set on narratives written by author

Create a narrative

Sun Pharmaceutical Industries

AN

AnalystConsensusTarget

Consensus Narrative from 36 Analysts

Efficient R&D And Specialty Pipeline Expansion Will Strengthen Future Competitive Positioning

Key Takeaways Specialty sales growth and strategic acquisitions in key therapeutic areas could enhance Sun Pharma's market share and revenue through expanded product offerings and market reach. Increased R&D spending and robust performance in India and emerging markets suggest sustained revenue growth and competitive positioning in both generic and specialty segments.

₹2.05k

FV

18.1% undervalued

9.75%

Revenue growth p.a.

0

0

13

2 days ago